Literature DB >> 14639442

Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships.

Hung-Fu Tseng1, Hsiu-Fen Tan, Chen-Kang Chang, Wei-Lun Huang, Wong-Ching Ho.   

Abstract

BACKGROUND: Japanese encephalitis (JE) occurs all over Asia, especially in southeastern regions. The aim of this study was to evaluate the current JE vaccination regimen in Taiwan by assessing the neutralizing antibody among people of various age groups from different living environments.
METHODS: From 1998 to 1999, 2365 (1016 male, 1349 female) students and home-visit volunteers were recruited from an industrialized city (Kaohsiung), and 712 (290 male, 422 female) students and volunteers from hospital outpatient and physical check-up units were recruited from country townships (Pintung County) for this study. Participants were between 6 and 74 years old. Serum JE neutralizing antibody was measured by the plaque reduction neutralization test with a 50% reduction as seroconversion. Incidence cases from 1971 to 1999 were collected from an active surveillance system run by the Center for Disease Control in Taiwan.
RESULTS: Seropositive prevalence peaked immediately after the second booster in first-grade students and declined as age increased. For those born before 1963, seropositive prevalence was significantly associated with age, sex, and living area. In the 1990s, the incidences of confirmed JE in Kaohsiung and Pintung County were 0.11 and 0.14 per 100,000 population, with only 2 and 1 patient age 10 years or younger, respectively. All but 2 patients had never been vaccinated.
CONCLUSIONS: Seropositive prevalence decreased gradually after vaccination. A third booster (the fifth shot) before age 18 years may further enhance the antibody titers, especially if the odds of natural infections have significantly reduced. Follow up studies on the changes of antibody titers over time among immunized populations are warranted in Asian countries where natural infections become less common.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639442     DOI: 10.1067/mic.2003.73

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  11 in total

1.  A novel low-cost approach to estimate the incidence of Japanese encephalitis in the catchment area of three hospitals in Bangladesh.

Authors:  Repon C Paul; Mahmudur Rahman; Emily S Gurley; M Jahangir Hossain; Serguei Diorditsa; Asm Mainul Hasan; Sultana S Banu; Asm Alamgir; Muhammad Aziz Rahman; Hardeep Sandhu; Marc Fischer; Stephen P Luby
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

2.  Epidemiological Features of Japanese Encephalitis in Taiwan from 2000 to 2014.

Authors:  Yu-Kang Chang; Hsiao-Ling Chang; Ho-Sheng Wu; Kow-Tong Chen
Journal:  Am J Trop Med Hyg       Date:  2016-11-07       Impact factor: 2.345

3.  Decreases in Both the Seroprevalence of Serum Antibodies and Seroprotection against Japanese Encephalitis Virus among Vaccinated Children.

Authors:  Ran Wang; Lyu Xie; Na Gao; Dongying Fan; Hui Chen; Peigang Wang; Hongning Zhou; Jing An
Journal:  Virol Sin       Date:  2019-03-25       Impact factor: 4.327

4.  Effectiveness of the Viet Nam produced, mouse brain-derived, inactivated Japanese encephalitis vaccine in Northern Viet Nam.

Authors:  Florian Marks; Thi Thu Yen Nguyen; Nhu Duong Tran; Minh Hong Nguyen; Hai Ha Vu; Christian G Meyer; Young Ae You; Frank Konings; Wei Liu; Thomas F Wierzba; Zhi-Yi Xu
Journal:  PLoS Negl Trop Dis       Date:  2012-12-13

Review 5.  Epidemiology of Japanese encephalitis: past, present, and future prospects.

Authors:  Huanyu Wang; Guodong Liang
Journal:  Ther Clin Risk Manag       Date:  2015-03-19       Impact factor: 2.423

6.  Comparison of four serological tests for detecting antibodies to Japanese encephalitis virus after vaccination in children.

Authors:  Go Woon Cha; Jung Eun Cho; Young Ran Ju; Young-Jin Hong; Myung Guk Han; Won-Ja Lee; Eui Yul Choi; Young Eui Jeong
Journal:  Osong Public Health Res Perspect       Date:  2014-09-06

7.  Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

Authors:  Mya Myat Ngwe Tun; Aung Kyaw Kyaw; Khine Mya Nwe; Shingo Inoue; Kyaw Zin Thant; Kouichi Morita
Journal:  Vaccines (Basel)       Date:  2021-05-31

8.  Occurrence of Japanese encephalitis virus mosquito vectors in relation to urban pig holdings.

Authors:  Johanna Lindahl; Jan Chirico; Sofia Boqvist; Ho Thi Viet Thu; Ulf Magnusson
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

9.  The incidence of Japanese encephalitis in Taiwan--a population-based study.

Authors:  Li-Ching Hsu; Yu-Ju Chen; Feng-Kuang Hsu; Jyh-Hsiung Huang; Chi-Ming Chang; Pesus Chou; I-Feng Lin; Feng-Yee Chang
Journal:  PLoS Negl Trop Dis       Date:  2014-07-24

10.  Seroprevalence of dengue virus in two districts of Kaohsiung City after the largest dengue outbreak in Taiwan since World War II.

Authors:  Jih-Jin Tsai; Ching-Kuan Liu; Wen-Yang Tsai; Li-Teh Liu; Jasmine Tyson; Ching-Yi Tsai; Ping-Chang Lin; Wei-Kung Wang
Journal:  PLoS Negl Trop Dis       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.